Data collected through semi-structured interviews with key stakeholders possessing different expertise and backgrounds to understand their approach to the implementation of a potential new TB vaccine. A total of 26 stakeholders were interviewed during April and May 2025. Interviews were conducted individually or as groups, either online and in-person.